Clinical

Dataset Information

0

Azacitidine and CAPOX in Metastatic Colorectal Cancer


ABSTRACT: The goal of the Phase I portion of this study is to find the highest tolerable dose of azacitidine combined with capecitabine and oxaliplatin (CAPOX) that can be given to patients with metastatic colorectal cancer. The goal of the Phase II portion of this study is to learn if azacitidine, given in combination with CAPOX, can help to control metastatic colorectal cancer. The safety of this drug combination will also be studied.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2094460 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| phs001318 | dbGaP
| 2246662 | ecrin-mdr-crc
2016-03-30 | E-GEOD-66732 | biostudies-arrayexpress
2017-03-08 | GSE84440 | GEO
| 2218156 | ecrin-mdr-crc
2020-05-28 | GSE151317 | GEO
2016-03-30 | GSE66732 | GEO
| 2042092 | ecrin-mdr-crc
2020-05-20 | GSE150298 | GEO
2021-09-10 | GSE158813 | GEO